View drug registration information details.
| Items | Registration information |
|---|
| ID | 1629 |
|---|
| No | 1629 |
|---|
| Brand Name | APIXA |
|---|
| Ingredients | APIXABAN 2.5 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 28 TABLETS/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | REDUCING THE RISK OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WHO HAVE NONVALVULAR ATRIAL FIBRILLATION, PROPHYLAXIS OF DEEP VEIN THROMBOSIS(DVT) LEADING TO PULMONARY EMBOLISM(PE) IN PATIENTS AFTER A HIP OR KNEE REPLACEMENT SURGERY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | YELLOW ROUND TABLET |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 09 L 1018/23 |
|---|
| FDD Registration Date | 20-SEP-2023 |
|---|
| Expiry Date | 19-SEP-2026 |
|---|
Back to drug list
|
